Jenny Zhang
- Two phase 3 placebo-controlled trials of aztreonam lysine for inhalation (AZLI) for non-cystic fibrosis bronchiectasis (NCFB)By Alan Barker, Anne O'Donnell, Philip J. Thompson, Patrick Flume, Jonathan Ruzi, Javier de Gracia, Wim Boersma, Eva Polverino, Lixin Shao, Jenny Zhang, Sheila Leitzinger, Laura Haas, Matt McKevitt, A. Bruce Montgomery, Alexandra Quittner, David Gossage and Thomas O'RiordanAlan Barker1Pulmonary and Critical Care, Oregon Health and Science University, Portland, OR, United StatesAnne O'Donnell2Division of Pulmonary, Critical Care and Sleep Medicine, Georgetown University Medical Center, Washington DC, United StatesPhilip J. Thompson3Lung Institute of Western Australia, Sir Charles Gairdner Hospital, Nedlands, WA, AustraliaPatrick Flume4Pulmonary & Critical Care Medicine, Medical University of South Carolina, Charleston, SC, United StatesJonathan Ruzi5Pulmonary Medicine, AZ Pulmonary Specialists, LTD, Scottsdale, AZ, United StatesJavier de Gracia6Servicio Neumologia, Hospital Vall d'Hebrón-Servicio Neumologia, Barcelona, SpainWim Boersma7Department of Pulmonology, Medical Center Alkmaar, Alkmaar, NetherlandsEva Polverino8Servei de Neumologia, Hospital Clinic i Provincial-Servicio de Neumologia, Barcelona, SpainLixin Shao9Biostatistics, Gilead Sciences, Inc., Foster City, CA, United StatesJenny Zhang9Biostatistics, Gilead Sciences, Inc., Foster City, CA, United StatesSheila Leitzinger10Clinical Research, Gilead Sciences, Inc., Seattle, WA, United StatesLaura Haas10Clinical Research, Gilead Sciences, Inc., Seattle, WA, United StatesMatt McKevitt10Clinical Research, Gilead Sciences, Inc., Seattle, WA, United StatesA. Bruce Montgomery11CEO, Cardeas Pharma, Seattle, WA, United StatesAlexandra Quittner12Department of Psychology, University of Miami, Miami, FL, United StatesDavid Gossage10Clinical Research, Gilead Sciences, Inc., Seattle, WA, United StatesThomas O'Riordan10Clinical Research, Gilead Sciences, Inc., Seattle, WA, United States
- Late-breaking abstract: The Guangzhou COPD exacerbation study: Relationship of exacerbations with viral infections and soluble biomarkersBy Christopher McCrae, Yumin Zhou, Jin Qian, Jenny Xia, Christina Wang, Marleen van Geest, Renhong Tang, Li Zheng, Changting Liu, Anna Nilsson, Meizhuo Zhang, Ziad Taib, Jinping Zheng, Piet Bruijnzeel, Yi Gu, Rongchang Chen and Nanshan ZhongChristopher McCrae1Respiratory, Inflammation & Autoimmunity (RIA) Innovative Medicines Unit, AstraZeneca R&D Mölndal, Mölndal, SwedenYumin Zhou2Guangzhou Institute of Respiratory Disease, Guangzhou Medical University, Guangzhou, ChinaJin Qian3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaJenny Xia3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaChristina Wang3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaMarleen van Geest1Respiratory, Inflammation & Autoimmunity (RIA) Innovative Medicines Unit, AstraZeneca R&D Mölndal, Mölndal, SwedenRenhong Tang3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaLi Zheng3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaChangting Liu3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaAnna Nilsson1Respiratory, Inflammation & Autoimmunity (RIA) Innovative Medicines Unit, AstraZeneca R&D Mölndal, Mölndal, SwedenMeizhuo Zhang3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaZiad Taib1Respiratory, Inflammation & Autoimmunity (RIA) Innovative Medicines Unit, AstraZeneca R&D Mölndal, Mölndal, SwedenJinping Zheng2Guangzhou Institute of Respiratory Disease, Guangzhou Medical University, Guangzhou, ChinaPiet Bruijnzeel1Respiratory, Inflammation & Autoimmunity (RIA) Innovative Medicines Unit, AstraZeneca R&D Mölndal, Mölndal, SwedenYi Gu3Asia & Emerging Markets Innovative Medicines Unit, AstraZeneca R&D Shanghai, Shanghai, ChinaRongchang Chen2Guangzhou Institute of Respiratory Disease, Guangzhou Medical University, Guangzhou, ChinaNanshan Zhong2Guangzhou Institute of Respiratory Disease, Guangzhou Medical University, Guangzhou, China
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.